Indeed as shown in Fig 4A, GC patients with higher levels of Alb (40–49.7 g/L) showed better survival than those with lower levels of Alb (20.3–39.9 g/L), and this was also true when patients were categorized according to the median range (Alb 39.2–49.7 g/L vs. 20.3–39.0 g/L, Fig 4B). This evidence concerns the gene ALB and gastric cancer.